|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash (used in) provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Interest paid in kind | |||||
| Stock-based compensation | |||||
| Change in fair value of bifurcated embedded derivatives | |||||
| Amortization of debt discount | |||||
| Deferred income taxes | |||||
| Change in fair value of contingent consideration liability | |||||
| Accretion of preferred stock | |||||
| Loss on extinguishment of debt | |||||
| Settlement of accrued expenses | |||||
| Change in fair value of digital assets | |||||
| Impairment of fixed asset | |||||
| Impairment of goodwill | |||||
| Impairment of intangibles | |||||
| Provision for credit losses | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other current assets | |||||
| Inventories | |||||
| Other assets | |||||
| Deferred revenue | |||||
| Accounts payable and accrued liabilities | |||||
| Accrued royalties | |||||
| Other liabilities | |||||
| Net cash (used in) provided by operating activities | |||||
| Cash Flows from Investing Activities: | |||||
| Purchases of property and equipment | |||||
| Purchase of digital assets | |||||
| Purchase of intangible assets | |||||
| Net cash used in investing activities | |||||
| Cash Flows from Financing Activities: | |||||
| Payment of contingent consideration | |||||
| Proceeds on notes payable – related party | |||||
| Repayment of notes payable – related party | |||||
| Payment of dividends | |||||
| Payments on Capchase loan | |||||
| Capchase | |||||
| Podcast One Bridge Loan | |||||
| Total payments on Capchase loan | |||||
| Repayment on line of credit | |||||
| Proceeds from notes payable | |||||
| Repayments of notes payable | |||||
| Proceeds from Bridge Loan | |||||
| Proceeds from exercise of stock options | |||||
| Proceeds from common stock offering, net of issuance costs | |||||
| Proceeds from convertible debt, net of issuance costs | |||||
| Repayment of convertible debt | |||||
| Purchases of treasury stock | |||||
| Net cash provided by (used in) financing activities | |||||
| Cash, cash equivalents and restricted cash, beginning of year | |||||
| Cash, cash equivalents and restricted cash, end of year | |||||
| Net change in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of year | |||||
| Cash, cash equivalents and restricted cash, end of year | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid for income taxes | |||||
| Cash paid for interest | |||||
| Supplemental disclosure of non-cash investing and financing activities: | |||||
| Debt Conversion, Original Debt | |||||
| Conversion of Bridge Loan into PodcastOne Common Stock | |||||
| Bridge Loan Accrued Interest Converted to Common Stock | |||||
| Conversion of Unsecured Convertible Notes to Series A-1 Preferred Stock | |||||
| Common stock issued to settle accrued expenses | |||||
| Non-cash settlement of contingent consideration in exchange for 414,137 shares of common stock | |||||
| 1,259,188 shares of common stock issued to consultant and vendors to settle accounts payable | |||||
| Fair value of warrant and derivative liabilities issued with debt and equity instruments | |||||
| Fair value of shares received of PodcastOne common stock to settle payables owed | |||||
| Accrual of dividends | |||||
| PodcastOne warrants reclassed from liabilities to non-controlling interest | |||||
| Fair value of 2,075,000 and 1,248,797 shares issued in connection with Senior Secured Convertible Notes and Unsecured Convertible Notes modification and extinguishment | |||||
| Fair value of common stock options and restricted stock issued to employees, capitalized as internally-developed software | |||||
| Accrued expenses written off associated with intangible asset impairment | |||||
| Additions of ROU Assets | |||||
| Purchase of intangible assets accrued for at period end | |||||
| Purchase of intangible assets with common stock | |||||
Loading...